Menu Search
Equities

Solasto Corp

6197:TYO

Solasto Corp

Actions
Health CareHealth Care Providers
  • Price (JPY)472.00
  • Today's Change-3.00 / -0.63%
  • Shares traded307.30k
  • 1 Year change-19.86%
  • Beta1.1102
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform1
Hold3
Sell0
Strong Sell0

Share price forecast in JPY

The 3 analysts offering 12 month price targets for Solasto Corp have a median target of 620.00, with a high estimate of 880.00 and a low estimate of 550.00. The median estimate represents a 31.36% increase from the last price of 472.00.
High86.4%880.00
Med31.4%620.00
Low16.5%550.00

Dividends in JPY

In 2024, Solasto Corp reported a dividend of 20.00 JPY, equaling last years dividend. The 3 analysts covering the company expect dividends of 20.00 JPY for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in JPY

Solasto Corp reported annual 2024 earnings of 24.11 per share on May 06, 2024.
Average growth rate-16.07%
More ▼

Revenue history & estimates in JPY

Solasto Corporation had 2nd quarter 2025 revenues of 34.29m. This missed the 34.70m estimate of the one analyst following the company. This was 4.14% above the prior year's 2nd quarter results.
Average growth rate+0.17%
Solasto Corporation had revenues for the full year 2024 of 135.14m. This was 3.09% above the prior year's results.
Average growth rate+9.06%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.